MAPK-INHIBITOREN

European patent · EP3186245 · In force

Register entry

Publication number
EP3186245
Application number
EP15835823
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 25, 2015
Published
Jul 5, 2017
Granted
Jun 23, 2021
Protection ends at the latest
Aug 24, 2035
Next annual fee due
Aug 31, 2027
IPC classes
C07D 409/04 (2006.01)
C07D 409/14 (2006.01)
A61K 31/4436 (2006.01)
A61K 31/444 (2006.01)
A61P 37/00 (2006.01)
A61P 29/00 (2006.01)
Priority
AU 2014903342 25.08.2014
PCT application
PCT/AU2015/050490 25.08.2015
PCT publication
WO2016/029263 03.03.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. May 4, 2022

    Change

    Published in Swissreg on 04.05.2022

  7. Jun 23, 2021

    Granted

    Published in Swissreg on 23.06.2021

Parties

Inventor

SIMPSON, Jamie

Brunswick, Victoria 3056, AU

SCAMMELLS, Peter

North Balwyn, Victoria 3104, AU

WANG, Bing Hui

Camberwell, Victoria 3124, AU

CHALMERS, David

Clayton, Victoria 3800, AU

KRUM, Henry

Malvern, Victoria 3144, AU

VINH, Natalie

Vermont South, Victoria 3133, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.